Jason Wittes

Stock Analyst at Roth Capital

(2.60)
# 1,812
Out of 5,182 analysts
58
Total ratings
48.08%
Success rate
3.75%
Average return

Stocks Rated by Jason Wittes

ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $7.95
Upside: +403.14%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405$456
Current: $329.01
Upside: +38.60%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15$16
Current: $2.27
Upside: +604.85%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $12.32
Upside: +78.57%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60$72
Current: $89.01
Upside: -19.11%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $4.50
Upside: +144.44%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100$115
Current: $93.70
Upside: +22.73%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $5.26
Upside: +109.13%
Cardiol Therapeutics
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.40
Upside: +614.29%
LeMaitre Vascular
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $114.52
Upside: -12.68%
Reiterates: Buy
Price Target: $5
Current: $1.93
Upside: +159.07%
Initiates: Buy
Price Target: $9
Current: $0.44
Upside: +1,924.29%
Initiates: Buy
Price Target: $75
Current: $24.54
Upside: +205.62%
Initiates: Buy
Price Target: $22
Current: $10.36
Upside: +112.36%
Initiates: Neutral
Price Target: $120
Current: $92.59
Upside: +29.60%
Initiates: Buy
Price Target: $206
Current: $178.66
Upside: +15.30%
Reinstates: Buy
Price Target: $145
Current: $198.70
Upside: -27.03%
Initiates: Buy
Price Target: $7.5
Current: $16.50
Upside: -54.55%
Initiates: Buy
Price Target: $200
Current: $12.48
Upside: +1,502.56%
Initiates: Buy
Price Target: $26
Current: $35.38
Upside: -26.51%